Trial watch: Novel antimicrobial fights TB resistance.
Sarah
S
Crunkhorn
D000995:Antitubercular Agents / Q000494:pharmacology*; D017322:Clinical Trials, Phase II as Topic; D015195:Drug Design; D006801:Humans; D055118:Medication Adherence; D009169:Mycobacterium tuberculosis; D009593:Nitroimidazoles / Q000494:pharmacology*; D010080:Oxazoles / Q000494:pharmacology*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents; D009593:Nitroimidazoles; C516022:OPC-67683; D010080:Oxazoles